$1.400
-0.136 (-9.68%)收盘时
- 最高
- 1.490
- 开盘
- 1.475
- 成交量加权均价
- 1.42
- 成交量
- 5.02M
- 市值
- —
- 最低
- 1.370
- 成交额
- 7.13M
- 企业价值/息税折旧摊销前利润(TTM)
- 0.00
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
AI 分析 of Qtrex Quantum Ltd (QTEX)
持有QTEX is currently not a strong buy due to its recent significant price drop of 19.79% over the last 5 days, despite a remarkable year-to-date increase of 294.74%. The RSI stands at 53.665, indicating a neutral momentum, while the forward P/E ratio of 8.2508 suggests potential value. However, the risk remains high with a negative net margin of -408.88% in the latest quarter, which could impact future profitability.
估值指标
事件时间线
资讯
8.510-19NewsfilterQTREX Quantum Regains Nasdaq Compliance with Minimum Bid Price
8.510-14NewsfilterQTREX Quantum Fully Exercises All Warrants Held by Shareholder
8.510-14NewsfilterQTREX Quantum Announces Clean Capital Structure and High-Density Interconnect Architecture
8.510-09NewsfilterQTREX Shares Recover Above $1 for Six Days
9.509-29NewsfilterNetSol Technologies Reports Strongest Fiscal Year 2026 Results
QTEX 常见问题 —— 由 Alphio AI 解答
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
QTEX is currently not a strong buy due to its recent significant price drop of 19.79% over the last 5 days, despite a remarkable year-to-date increase of 294.74%. The RSI stands at 53.665, indicating a neutral momentum, while the forward P/E ratio of 8.2508 suggests potential value. However, the risk remains high with a negative net margin of -408.88% in the latest quarter, which could impact future profitability.
社区
更多 ↗暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。